Wegovy Injection

At Emirates Hospitals Group our team of Endocrinologists, Internists and Family Medicine Doctors are expects at assessing which weight loss medication, if needed, is appropriate for your individual needs. Wegovy is a GLP-1 receptor agonist, has emerged as a promising medication for individuals struggling with obesity or overweight. This treatment offers a potential solution for those who have difficulty losing weight through diet and exercise alone.

What is Wegovy?

Wegovy is a once-weekly injection that works by mimicking the effects of a naturally occurring hormone called glucagon-like peptide-1 (GLP-1). This hormone helps regulate appetite, blood sugar levels, and digestion. By mimicking GLP-1, Wegovy can help reduce hunger, increase feelings of fullness, and slow down the emptying of the stomach.

Why is Wegovy Prescribed?

Wegovy is prescribed to individuals with obesity or are overweight who have at least one weight-related condition, such as high blood pressure, type 2 diabetes, or high cholesterol. It is intended to help people lose weight and maintain weight loss over time.

Benefits of Wegovy

• Significant Weight Loss: Studies have shown that Wegovy can help individuals lose a significant amount of weight, often more than what can be achieved through diet and exercise alone.
• Improved Blood Sugar Control: For individuals with type 2 diabetes, Wegovy can help improve blood sugar control.
• Reduced Risk of Heart Disease: By helping to lower body weight and improve other health factors, Wegovy may reduce the risk of heart disease.

Risks of Wegovy

Like any medication, Wegovy may have side effects. Common side effects include:

• Nausea
• Vomiting
• Diarrhea
• Constipation
• Stomach pain.

These side effects typically improve over time.

Wegovy vs Mounjaro

While Wegovy and Mounjaro are both GLP-1 receptor agonists, they have some key differences:

• Combination vs. Single Agent: Mounjaro is a combination of two GLP-1 receptor agonists (GLP-1 and GIP), while Wegovy is a single agent.
• Dosage: Mounjaro is administered once weekly, while Wegovy can be administered either once weekly or once monthly.
• Approval: Wegovy is specifically approved for weight management, while Mounjaro is primarily approved for the treatment of type 2 diabetes.

Determining the Right Medication for You

The best medication for you will depend on your individual circumstances, including your weight, health conditions, and preferences. Your healthcare provider will carefully assess your needs and recommend the most appropriate treatment.

If you are considering Wegovy or another weight loss medication, it is important to discuss the potential benefits and risks with your doctor to determine if it is the right choice for you.